Valuation eFFECTOR Therapeutics, Inc. Boerse Muenchen

Stocks

Real-time Boerse Muenchen			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

11/09/24	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
08/07/24	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	334.3	17.91	30.2
Change	-	-94.64%	68.61%
Enterprise Value (EV) ¹	304.6	11.88	32.38
Change	-	-96.1%	172.45%
P/E	18.8x	-0.78x	-0.71x
PBR	19.3x	4.58x	-6.01x
PEG	0x	0x	-0x
Capitalization / Revenue	233,760,757x	5,041,796x	-
EV / Revenue	-	-	-
EV / EBITDA	-9.56x	-0.37x	-0.96x
EV / EBIT	-9.55x	-0.37x	-0.96x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	11	-13.76	-16.37
Distribution rate	-	-	-
Net sales	1.43	3.553	-
EBITDA ¹	-31.87	-32.35	-33.73
EBIT ¹	-31.9	-32.4	-33.84
Net income ¹	15.8	-22.66	-35.81
Net Debt ¹	-29.67	-6.029	2.175
Reference price ²	207.000000	10.690000	11.685000
Nbr of stocks (in thousands)	1,615	1,676	2,585
Announcement Date	16/03/22	08/03/23	26/03/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
WUXI APPTEC CO., LTD.	21.8x	7.74x	15.55x	1.36%	74.27B
ARGENX SE	31.81x	9.18x	28.6x	0.04%	61.21B
WUXI BIOLOGICS (CAYMAN) INC.	31.83x	6.79x	17.62x	-.--%	27.55B
INSMED INCORPORATED	-73.75x	14.26x	-68.76x	-.--%	26.38B
BIONTECH SE	-15.46x	5.96x	-7.5x	-.--%	25.34B
GENMAB A/S	28.48x	5.36x	17.82x	-.--%	20.84B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1066.25x	37.33x	644.76x	-.--%	14.94B
PHARMAESSENTIA CORPORATION	43.75x	16.03x	32.53x	0.34%	15.17B
EXELIXIS, INC.	17.96x	5.35x	12.5x	-.--%	14.41B
Average	128.07x	12.00x	77.01x	0.19%	31.12B
Weighted average by Cap.	69.79x	10.14x	43.06x	0.39%